Home » Market Downgrades

Myriad Genetics, Inc. (MYGN) Downgraded to Hold at Auriga

Myriad Genetics, Inc. (MYGN) has been downgraded today by the securities research analysts at investment firm Auriga which cut Myriad Genetics from a “buy” rating to “hold.”  Myriad Genetics also lowered target outlook for Myriad Genetics, adjusting their price target from $27 to $25 dollars.  Auriga noted that their downgrade today is based on valuation of MYGN. MGYN gapped down at the open of the regular trading session this morning at the $23.29 price mark.  Shares would eventually be traded at one point within Tuesday’s... 
 

Gerber Scientific, Inc. (GRB) Downgraded to Hold at Needham Following Takeover

Gerber Scientific, Inc. (GRB) has been downgraded today by the securities research analysts at investment firm Needham which cut Gerber Scientific from a “buy” rating to “hold.”  Needham does not have a current price target performance outlook for the GRB.  Needham provided the rating change post-takeover bid from Vector Capital worth $281.80 million dollars, or $11.00 per share.  The acquisition took place yesterday. GRB massively gapped up at the beginning of the normal market session yesterday and shares rode a price... 
 

Molson Coors Brewing (TAP) Downgraded to Hold at Stifel Nicolaus

Molson Coors Brewing (TAP) has been downgraded today by the securities research analysts at investment firm Stifel Nicolaus which lowered Molson Coors Brewing from a “buy” rating to “hold.”  While Stifel Nicolaus did not provide any price target expectation on TAP they did mention that the company may jointly bid for Foster’s and noted the company does not have much interest in balancing its own balance sheet which lowers its options of following through with significant acquisitions. Shares of TAP gapped down during... 
 

Investment Technology Group (ITG) Downgraded to Neutral at Wedbush

Investment Technology Group, Inc. has been downgraded today by the securities research analysts at investment firm Wedbush which lowered Investment Technology from a “outperform” rating to “neutral” noting that they foresee the potential for decreased consensus revisions for ITG throughout 2011.  Wedbush also lowered their performance outlook for Wedbush by adjusting their price target from $20 to $15 dollars. ITG has set a new 52-week low today, reaching a low of $13 dollars.  Shares of ITG have been on the downturn... 
 

Gap, Inc. (GPS) Downgraded to Equal Weight at Barclays Capital

Gap, Inc. (GPS) has been downgraded today by the securities research analysts at investment firm Barclays Capital which lowered Gap from a “overweight” rating to “equal weight.”  Barclays noted they see risk regarding future earnings estimates and are not positive that there will not be earnings revisions in the future.  Barclays also decreased their performance outlook for ‘GPS’  and adjusted their price target from $22 to $17 dollars.  GPS gapped down during the open of the normal market session and has... 
 

Corn Products International (CPO) Downgraded at Deutsche Bank

Corn Products International, Inc. has been downgraded today by the securities research analysts at investment firm Deutsche Bank which downgraded Corn Products International from a “buy” rating to “hold.”  Deutsche Bank did not adjust their price target on CPO which is currently fixed at $62 dollars.  CPO is up during intraday trading for the first time in five days of trading.  Noteworthy is that the company representatives are expected to attend the Deutsche Bank Global Consumer Conference on June 14th, 2011. Corn... 
 

Lorillard, Inc. (LO) Downgraded at Davenport Despite Confidence in Management

Lorillard, Inc. (LO) has been downgraded today by the securities research analysts at investment firm Davenport which downgraded Lorillard from a former “buy” rating to “neutral,” despite standing confidence in Lorillard’s management team and core business success.  Davenport anticipates LO to weaken as June 22nd, 2011 draws closer and noted this is when the revised TPSAC menthol report will be posted by the FDA.  Lorillard does not expect the FDA to ban menthol in cigarettes, however. Davenport did not give a... 
 

Shanda Interactive Entertainment (SNDA) Downgraded at HSBC Securities

Shanda Interactive Entertainment (SNDA) has been downgraded today by the securities research analysts at investment firm HSBC Securities which decreased Shanda Interactive from a “neutral” rating to “underweight.”  HSBC noted that Shanda’s platform strategy is not producing desired results.  HSBC also slightly dropped their performance outlook for Shanda, adjusting their price target from $43 to $41 dollars.  ‘SNDA’ is down during intraday trading. Shanda Interactive is slated to release their next... 
 

Check Point Software Technologies Ltd. (CHKP) Downgraded to Hold at Davenport

Check Point Software Technologies Ltd. (CHKP) has been downgraded today by the securities research analysts at investment firm Davenport which downgraded Check Point from a “buy” rating to “hold” noting they believe the company is close to being fairly valued at this time.  Davenport did not provide a price target adjustment for the company.  ‘CHKP’ is up during intraday trading and is continuing its sixth consecutive day of overall bullish momentum despite today’s downgrade by Davenport. Check Point... 
 

Exide Technologies (XIDE) Downgraded to Underperform at Wedbush

Exide Technologies (XIDE) has been downgraded today by the securities research analysts at investment firm Wedbush which lowered their performance outlook of Exide from a “neutral” rating to “underperform.”  Wedbush also lowered their price target on XIDE  from $12 to $7 dollars.  XIDE gapped down during intraday trading posting the third highest day of volume within the past year. Exide is slated to release their next earnings report on August 4th, 2011 and the current EPS consensus estimate is 3 cents.  Their last... 
 

China-Biotics, Inc. (CHBT) Downgraded to Sell at Maxim Group

China-Biotics, Inc. (CHBT) has been downgraded today by the securities  research analysts at investment firm Maxim Group which downgraded CHBT from a “hold” rating to “sell.”  Maxim has a performance outlook price target of $6 dollars on CHBT.  CHBT is down during intraday trading and has trended beneath intermediate support of the $7.22 price level. China-Biotics is slated to release their next earnings report next Thursday on June 9th, 2011 and the current EPS consensus estimate is 51 cents.  Their last earnings report... 
 

Hill International, Inc. (HIL) Downgraded to Hold at Morgan Joseph

Hill International, Inc. (HIL) has been downgraded today by the securities research analysts at investment firm Morgan Joseph which lowered their performance outlook of HIL from “buy” rating to “hold.”  Morgan Joseph did not provide a price target for HIL.  HIL has ranged wildly during intraday trading after opening slightly higher than Tuesday’s market close. Hill International is slated to release their next earnings report on August 4th, 2011 and the current EPS consensus estimate is a negative 2 cents.  Their... 
 

Lions Gate Entertainment (LGF) Downgraded to Below Average at Caris & Company

Lions Gate Entertainment (LGF) has been downgraded today by the research analysts at investment firm Caris & Company which lowered LGF from an “average” rating to “below average.”  Caris & Company did not adjust their standing price target for LGF from $5 dollars.  LGF is down during intraday trading. Lions Gate Entertainment is slated to release their next earnings report on August 30th, 2011  and is estimated to post EPS of a negative 7 cents.  Their last earnings report was released today on May 31st, 2011... 
 

Impax Laboratories (IPXL) Downgraded to Sector Perform at RBC Capital Markets

Impax Laboratories (IPXL) has been downgraded today by the research analysts at investment firm RBC Capital Markets which downgraded IPLX from a “sector perform” rating from “outperform.”  RBC Capital did not adjust their price target of $28 dollars on IPXL.  IPXL gapped down during the morning session however has recovered most of the morning loss. Impax Laboratories is slated to release their next earnings report on August 3rd, 2011  and is estimated to post EPS of 22 cents.  Their last earnings report was released... 
 

Full Circle Capital (FULL) Downgraded to Neutral at Ladenburg Thalmann

Full Circle Capital (FULL) has been downgraded today by the research analysts at investment firm Ladenburg Thalmann which downgraded FULL from a “buy” rating to “neutral.”  Ladenburg Thalmann also lowered their price target for FULL  from $10.25 to $8 dollars.  FULL is down during intraday trading, however during early trading it was up considerably over last last Friday’s close. FULL is currently trading above its 50-day moving average and 2011 is currently a down year for the company.  Volatility of share volume... 
 
Advertisement
Advertisement
© 2006-2015 Leoncheng.